Scholars Central

ArticlePublished 13 Feb 2017

SOME CONSIDERATIONS IN ANTIMALARIAL CHEMOTHERAPY OF SEVERE FALCIPARUM MALARIA

Authors: Butungeshwar Pradhan

Journal of Evidence-Based Medicine and Healthcare

Volume 4 · Issue 2 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

BACKGROUND Acute severe falciparum malaria is a pernicious and vicious circle of pathophysiologic state and is a medical emergency. The priority of treatment is the parenteral administration of safe and adequate doses of appropriate effective antimalarials given as soon as possible in the setting of the highest possible levels of clinical care. Decreasing mortality is more important than cure of malaria, thus survival of the patients is the key factor. Antimalarial drugs have stage specific actions on plasmodium falciparum. Artemisinin are most rapidly acting of known antimalarials and they have broadest time window of activity. Recent study showed decreased mortality of 34.7% was by intravenous artesunate instead of quinine. Currently, the therapeutic doses of intravenous artesunate to treat severe malaria are in the range of 2-2.4 mg/kg produces peak drug concentrations (Cmax) with great inter-individual variability with lower Cmax than needed for hyperparasitaemia to efficaciously cover each RBCs as infected cells can concentrate 100-300 fold more dihydroartemisinin (DHA) than the normal RBCs during the first 1-2 hrs. after dosing indicating that intravenous dose should be increased to a higher levels than current loading dose to treat severe malaria with hyperparasitaemia to decrease further morbidity and mortality.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Evidence-Based Medicine and Healthcare
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Butungeshwar Pradhan”